Rare diseases
Investigational molecules
Locations
Back to Ireland104 clinical trials in Galway, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Trimodulin for Adults Hospitalized with Severe Community-Acquired Pneumonia
IrelandStudy to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery
IrelandPhase III Trial Comparing ABVD vs A2VD Treatment With PET-Guided Radiation Therapy for Patients With Early Stage Hodgkin Lymphoma
IrelandStudy on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia
IrelandStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
IrelandStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
IrelandEpcoritamab plus rituximab versus rituximab alone in elderly, frail or unfit patients with newly diagnosed diffuse large B‑cell lymphoma
IrelandStudy of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6
IrelandStudy Comparing Two Cisplatin Dosing Schedules with Radiation for Patients with Advanced Head and Neck Cancer
IrelandStudy on the Effectiveness and Safety of Luveltamab Tazevibulin Compared to Chemotherapy in Women with Relapsed Platinum-resistant Ovarian Cancer
IrelandStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
IrelandA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
IrelandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on multiple myeloma, lung cancer, and various forms of breast cancer. Research includes novel therapeutic combinations and targeted treatments for both early-stage and metastatic conditions.
Investigating new treatment approaches using advanced targeted therapies and immunotherapy combinations.
Advanced research into blood-related cancers, particularly chronic lymphocytic leukemia and lymphoma. Studies evaluate novel drug combinations and treatment duration optimization.
Focusing on personalized treatment approaches based on measurable residual disease monitoring.
Innovative studies addressing hypertension and cardiovascular health, including research on obesity-related cardiovascular conditions and new therapeutic approaches.
Exploring novel interventions for blood pressure control and atherosclerosis prevention.
Clinical investigations focusing on chronic skin conditions, particularly atopic dermatitis and hidradenitis suppurativa, testing new therapeutic options.
Evaluating advanced treatments for patients requiring systemic therapy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
